SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma shines on getting nod to invest up to Rs 500 crore in Mankind Medicare

20 May 2026 Evaluate

Mankind Pharma is currently trading at Rs. 2569.20, up by 75.10 points or 3.01% from its previous closing of Rs. 2494.10 on the BSE.

The scrip opened at Rs. 2499.30 and has touched a high and low of Rs. 2,579.00 and Rs. 2499.25 respectively. So far 84377 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2726.75 on 15-Jul-2025 and a 52 week low of Rs. 1909.90 on 23-Mar-2026.

Last one week high and low of the scrip stood at Rs. 2,579.00 and Rs. 2,105.70 respectively. The current market cap of the company is Rs. 105894.59 crore.

The promoters holding in the company stood at 72.66%, while Institutions and Non-Institutions held 24.66% and 2.68% respectively.

Mankind Pharma has received approval to make additional investment of up to Rs 500 crore in Mankind Medicare, a wholly owned subsidiary, in one or more tranches. The funds will be utilized for capacity expansion and plant being setup.

The Board of Directors of the Company at its meeting held May 19, 2026, has approved the same.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Share Price

2336.90 -17.50 (-0.74%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×